EVAR术后临床结局报告的系统评价:报告标准依从性差
该系统评价检索2014至2018年MEDLINE和Embase,纳入84项报告择期肾下腹主动脉瘤EVAR临床结局的前瞻性研究和随机对照试验,评估结局报告范围及对2002年报告标准的依从性。结果显示技术成功报告率58.3%但仅47.6%给出定义且存在22种不同定义,临床成功仅22.6%报告并定义,全因死亡和动脉瘤相关死亡分别报告于85.7%和61.9%研究,并发症和死亡报告率低,多数研究未遵循报告指南。作者建议修改报告标准并建立EVAR核心结局集。
要点
- EVAR术后临床结局报告异质性大,仅少数研究遵循2002年报告标准。
- 技术成功报告率58.3%,但定义多样(22种),临床成功仅22.6%报告并定义。
- 建议更新报告标准并建立EVAR核心结局集以规范未来研究。
核心结论
- EVAR术后报告的临床结局种类繁多,少数研究遵循报告指南,建议修改报告标准并建立核心结局集。
主要发现
- 技术成功报告于49项(58.3%)研究,仅40项(47.6%)给出定义,共22种不同定义。
- 临床成功报告并定义于19项(22.6%)研究;动脉瘤破裂报告于27项(32.1%),破裂致死报告于11项(13.1%)。
- 全因死亡和动脉瘤相关死亡分别报告于72项(85.7%)和52项(61.9%)研究。
- 内漏I型报告于61项(72.6%),II型52项(61.9%),III型45项(53.6%),IV型13项(15.5%)。
- 并发症和死亡报告率低,平均仅18项(21.4%)和42项(50%)研究报告。
临床怎么用
- 临床医生解读EVAR文献时需注意结局定义异质性,优先参考遵循报告标准的研究。
- 未来研究应采纳统一的EVAR核心结局集以提高证据可比性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular aneurysm repair (EVAR) is an established treatment for many patients with infra-renal abdominal aortic aneurysm (AAA). Reporting standards were published in 2002 to ensure consistent measurement and reporting of outcomes following EVAR. We aimed to assess the range of clinical outcomes reported after EVAR and whether recent studies adhere to established reporting standards. METHODS: We searched MEDLINE and Embase from January 2014 until December 2018, using terms for 'EVAR' and 'AAA'. We included prospective studies and randomised controlled trials which reported clinical outcomes of elective infra-renal AAA repair. Data on clinical outcome reporting were extracted and compared with established reporting standards. RESULTS: 84 studies were included. Technical success was reported in 49 (58.3%) studies, but only defined in 40 (47.6%), with 22 distinct definitions. Clinical success was reported and defined in 19 (22.6%) studies. Aneurysm rupture was reported in 27 (32.1%) studies and death from rupture in 11 (13.1%) studies. All-cause and aneurysm-related mortality were reported in 72 (85.7%) and 52 (61.9%) studies, respectively. Endoleak type I (n = 61, 72.6%) and II (n = 52, 61.9%) were more commonly reported than type III (n = 45, 53.6%) or IV (n = 13, 15.5%). Complications and mortality were reported by a mean of 18 (21.4%) and 42 (50%) studies, respectively. CONCLUSIONS: A wide variety of clinical outcomes were reported following EVAR. Few studies adhered to reporting guidelines. We recommend modification of reporting standards to reflect advances in endovascular technology and creation of a core outcome set for EVAR.
引用
- Alexander HC, Nguyen CH, Bartlett AS, et al. Reporting of Clinical Outcomes After Endovascular Aortic Aneurysm Repair: A Systematic Review. Ann Vasc Surg. 2021. PMID: 34437976. doi:10.1016/j.avsg.2021.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。